Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
3
Number of overlapping holdings
10.0%
% of FBT's 31 holdings also in PSIL
33.3%
% of PSIL's 28 holdings also in FBT
Overlap by Weight
Sector Drift (FBT minus PSIL)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FBT |
Weight in PSIL |
Overlap | |
|---|---|---|---|---|
 |
INTRA-CELLULAR THERAPIES INC | 4.2% | 4.5% | 4.2% |
|
NEUROCRINE BIOSCIENCES INC | 4.1% | 4.6% | 4.1% |
 |
ALKERMES PLC | 3.2% | 6.3% | 3.2% |
Position Highlights (Non-Overlapping Exposures)
FBT Overweight Relative to PSIL
|
EXELIXIS INC | 4.6% |
|
NATERA INC | 4.5% |
 |
ARGENX SE ADR | 4.1% |
|
ACADIA PHARMACEUTICALS INC | 3.9% |
|
REPLIGEN CORP | 3.7% |
|
CORCEPT THERAPEUTICS INC | 3.7% |
|
CATALYST PHARMACEUTICAL PART | 3.6% |
|
INCYTE CORP | 3.6% |
|
WATERS CORP | 3.6% |
|
GILEAD SCIENCES INC | 3.5% |
FBT Underweight Relative to PSIL
 |
ATAI LIFE SCIENCES N.V. | -6.4% |
|
INCANNEX HEALTHCARE INC. | -5.2% |
|
SAGE THERAPEUTICS INC | -4.3% |
|
ALKERMES PLC | -3.0% |
|
RELMADA THERAPEUTICS INC | -1.3% |
 |
NUMINUS WELLNESS INC | -1.2% |
|
NEUROCRINE BIOSCIENCES INC | -0.5% |
|
INTRA-CELLULAR THERAPIES INC | -0.3% |
|
NEURONETICS, INC. | -0.3% |
|
REGENERON PHARMACEUTICALS | 2.3% |